Roberta Pacifici

Roberta Pacifici

Auto-generated profile, based on publicly available information

Roberta Pacifici

Laboratorio di Biochimica Clinica, Istituto Superiore di Sanità, Roma

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2000 in International Journal of Immunopharmacology
Verified
Journal Article
Closed access
RPRoberta Pacifici
Roberta Pacifici
SCSimonetta di Carlo
Simonetta di Carlo
ABAntonella Bacosi
Antonella Bacosi
SPSimona Pichini
Simona Pichini
PZPiergiorgio Zuccaro
Piergiorgio Zuccaro

1 April 2003 in International Immunopharmacology
Verified
Journal Article
Closed access
RPRoberta Pacifici
Roberta Pacifici
AFAnna Ida Fiaschi
Anna Ida Fiaschi
Lucia MicheliLucia Micheli
Lucia Micheli
FCFabio Centini
Fabio Centini
GGGiorgio Giorgi
Giorgio Giorgi
DCDaniela Cerretani
Daniela Cerretani

26 June 2006 in International Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
RAR. Abellan
R. Abellan
RVR. Ventura
R. Ventura
SPSimona Pichini
Simona Pichini
IPI. Palmi
I. Palmi
MBM. Bellver
M. Bellver
JSJ. Segura
J. Segura
Erythropoietin (EPO) and soluble transferrin receptor (sTfR) in serum have been proposed as indirect biomarkers for the detection of recombinant human EPO (rhEPO) misuse in sport. The purpose of the present study was to investigate the influence of different levels of physical fitness, sport, different training workload during the sport season, and endurance exercise in the concentrations of these serum biomarkers for their application into mathematical models to indirectly detect rhEPO misuse. Serum EPO and sTfR concentrations were measured in 96 elite athletes of various sports along the sport season, in 21 recreational athletes at baseline (non exercising) conditions and in 129 other recreational athletes before and after long-distance races (10 and 21 km). In elite athletes, hemoglobin concentrations and percentage of reticulocytes were also measured, and indirect detection models applied. In recreational athletes, for EPO and sTfR, significant differences were only observed after the 21-km race. In baseline conditions, no differences were observed between recreational and elite athletes for EPO and sTfR. In elite athletes, individual EPO and sTfR concentrations slightly changed over the sport season, with coefficients of variation (CV) of 26.1 % and 9.0 %, respectively. Hemoglobin and reticulocytes were influenced by sport, but their individual variation over the sport season was not physiologically relevant (CV of 3.7 % and 21.3 %, respectively). When applying mathematical models for detection of rhEPO administration, only one elite athlete obtained an individual model score above the established thresholds. Physical fitness, sport and different training workload during the sport season had no substantial effect on serum EPO and sTfR concentrations, except in recreational athletes after a 21-km race. Variations observed in mathematical models to detect EPO administration were mainly due to fluctuation in hemoglobin concentrations, commonly observed in elite athletes.

1 April 1995 in Epilepsia
Verified
Journal Article
Closed access
RPR. Pacifici
R. Pacifici
PZP. Zuccaro
P. Zuccaro
PIP. Iannetti
P. Iannetti
URU. Raucci
U. Raucci
CIC. Imperato
C. Imperato


1 January 1989
Verified
Journal Article
Closed access
PZP Zuccaro
P Zuccaro
RPR Pacifici
R Pacifici
SPSimona Pichini
Simona Pichini
UAU Avico
U Avico
GFG Federzoni
G Federzoni
ESE Sternieri
E Sternieri